These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 9286651)
21. Intracavernosal endothelin levels of impotent men before and after papaverine induced penile erection. Kadioğlu A; Memişoğlu K; Sazoya O; Tüzün E Arch Esp Urol; 1998 Sep; 51(7):739-40. PubMed ID: 9807905 [TBL] [Abstract][Full Text] [Related]
22. Cutaneous temperature measurements in men with penile prostheses: a comparison study. Fogarty JD; Bleustein CB; Hafron JM; Melman A Int J Impot Res; 2005; 17(6):506-9. PubMed ID: 15889119 [TBL] [Abstract][Full Text] [Related]
24. Distribution of lidocaine and digoxin in heart tissues and aorta following intrapericardial administration. Darsinos JT; Samouilidou EC; Krumholz B; Kontoyanni M; Pistevos AK; Karli JN; Theodorakis MG; Levis GM; Moulopoulos SD Int J Clin Pharmacol Ther Toxicol; 1993 Dec; 31(12):611-5. PubMed ID: 8314364 [TBL] [Abstract][Full Text] [Related]
25. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group. Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184 [TBL] [Abstract][Full Text] [Related]
26. Gravity cavernosometry and assessment of complete smooth muscle relaxation: helpful in the differential diagnosis of cavernous leakage? de Meyer JM; Oosterlinck W Eur Urol; 1998; 33(5):441-6. PubMed ID: 9643662 [TBL] [Abstract][Full Text] [Related]
27. [Intra-cavernous injections of vasoactive drugs. A 10-year experience at an andrologic center]. Pozza D; Ossanna P; Cicchinelli C; Pozza M; Rizzo GL; Marchionni L Minerva Urol Nefrol; 1996 Sep; 48(3):163-7. PubMed ID: 8966654 [TBL] [Abstract][Full Text] [Related]
28. [Examination of free and fixed combination of Fludilat with digoxine]. Bartels H Med Welt; 1974 Nov; 25(44):1838-41. PubMed ID: 4431325 [No Abstract] [Full Text] [Related]
30. [Use of digoxin in a population cared for in the emergency department]. Knobel H; Nogués X Med Clin (Barc); 1994 Jan; 102(1):38. PubMed ID: 8133692 [No Abstract] [Full Text] [Related]
31. Pharmacodynamics of intracavernously injected drugs and cavernous wall resistance. de Meyer JM; Oosterlinck W Eur Urol; 1997; 32(2):184-9. PubMed ID: 9286651 [TBL] [Abstract][Full Text] [Related]
32. [The relationship of cavernous oxygen tension with erectile dysfunction of vascular origin]. Romero-Tejada JC; Fernández Borrell A; Fernández Arjona M; Pereira Sanz I Arch Esp Urol; 1998 Nov; 51(9):919-22. PubMed ID: 9887565 [TBL] [Abstract][Full Text] [Related]
33. Plasma levels of cavernous and systemic norepinephrine and epinephrine in men during different phases of penile erection. Becker AJ; Uckert S; Stief CG; Truss MC; Machtens S; Scheller F; Knapp WH; Hartmann U; Jonas U J Urol; 2000 Aug; 164(2):573-7. PubMed ID: 10893646 [TBL] [Abstract][Full Text] [Related]
34. [Methylene blue: an effective therapeutic alternative for priapism induced by intracavernous injection of vasoactive agents]. Martínez Portillo FJ; Fernández Arancibia MI; Bach S; Alken P; Jünemann KP Arch Esp Urol; 2002 Apr; 55(3):303-8. PubMed ID: 12068762 [TBL] [Abstract][Full Text] [Related]
35. [Response to intracavernous administration of 3 different drugs in the same group of patients with erectile dysfunction]. Ribé N; Rajmil O; Bassas L; Jurado C; Pomerol JM Arch Esp Urol; 2001 May; 54(4):355-9. PubMed ID: 11455770 [TBL] [Abstract][Full Text] [Related]